EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseOpen Access

Evaluation of the efficacy and safety of durvalumab combined with chemotherapy, radiotherapy, or other agents in advanced non-small cell lung cancer: a meta-analysis

Min Xu, Ran Cui, Xinlin Yu

International Journal of Clinical and Experimental Pathology · 2025

DOI: 10.62347/bnvx1803 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Clinical and Experimental Pathology, 2025. Verfasst von Min Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory, Affiliated Hospital Chengdu University Chengdu, Sichuan, China. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

DurvalumabNSCLCimmune checkpoint inhibitors

Autor:innen und Institutionen

  • Department of Respiratory, Affiliated Hospital Chengdu University Chengdu, Sichuan, China.
  • Department of Respiratory, The First People's Hospital of Neijiang Neijiang, Sichuan, China.
  • Department of Oncology, Affiliated Hospital Chengdu University Chengdu, Sichuan, China.

Zitieren

APA

Xu, M., Cui, R., & Yu, X. (2025). Evaluation of the efficacy and safety of durvalumab combined with chemotherapy, radiotherapy, or other agents in advanced non-small cell lung cancer: a meta-analysis. International Journal of Clinical and Experimental Pathology. https://doi.org/10.62347/bnvx1803

Vancouver

Xu M, Cui R, Yu X. Evaluation of the efficacy and safety of durvalumab combined with chemotherapy, radiotherapy, or other agents in advanced non-small cell lung cancer: a meta-analysis. International Journal of Clinical and Experimental Pathology. 2025. doi:10.62347/bnvx1803

BibTeX
@article{Xu2025,
  author = {Xu, Min and Cui, Ran and Yu, Xinlin},
  title = {Evaluation of the efficacy and safety of durvalumab combined with chemotherapy, radiotherapy, or other agents in advanced non-small cell lung cancer: a meta-analysis},
  journal = {International Journal of Clinical and Experimental Pathology},
  year = {2025},
  doi = {10.62347/bnvx1803}
}
Kostenlos starten →